Access to Medicines & Shortages

CPME Rapporteur: Dr Christiaan KEIJZER (NL), Dr Jacqueline Rossant-Lumbroso (FR)
CPME Secretariat: Marcin RODZINKA-VERHELLE

Featured Policies

Mar 2021 CPME 2021/011 FINAL
CPME Position Paper on the Pharmaceutical Strategy for Europe Download
Apr 2020 CPME 2020/005
CPME Policy on Medicine Shortages Download
Nov 2016 CPME 2016/063
CPME policy on access to medicines and pharmaceutical pricing Download

Other Policies

Sep 2023 CPME 2023/110
Response to the public survey on "Transparency Directive" Download
Aug 2023 CPME 2023/085 FINAL
CPME response to public consultation on the transparency rules for the operation of the Clinical Trials Regulation (CTR) and its Clinical Trials Information System (CTIS) Download
Feb 2023 CPME 2023/019
Feedback on the WHO/Europe Access to Novel Medicines Platform Download
Apr 2021 CPME 2021/053
CPME statement on the Oslo Medicines Initiative Download
CPME 2021/021
CPME Position Paper on the proposal for extending the EMA mandate Download
Dec 2020
Joint Statement on transparency on the EU vaccines negotiations Download
CPME Info 2020/079
Joint Statement on transparency of the EU vaccine negotiations Download
CPME 2020/065 FINAL
CPME response to public consultation on the Pharmaceutical Strategy for Europe Download
Sep 2020 CPME 2020/070
CPME response to public consultation on European Medicines Agencies Network Strategy to 2025 Download
CPME response to the roadmap to the European Commission’s Pharmaceutical Strategy Download
Joint statement on recommendations towards fair medicines prices in Europe Download
CPME amendments to the European Parliament’s draft INI report on the shortage of medicines Download
This website uses cookies for personalization to allow video functionality. More information our privacy policy.
Necessary cookies to provide the basic functionality of this website.
Cookies of 3rd party providers: YouTube